feed,title,long_url,short_url
BioRxiv,"Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication by targeting its major protease in a non-competitive way",https://biorxiv.org/cgi/content/short/2021.09.23.461605v1?rss=1,https://j.mp/3okR1MT
